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Acellular Urethra Bioscaffold: 
Decellularization of Whole Urethras 
for Tissue Engineering Applications
Irina N. Simões1,2,3, Paulo Vale4, Shay Soker2, Anthony Atala2, Daniel Keller3, Rute Noiva5, 
Sandra Carvalho5, Conceição Peleteiro5, Joaquim M. S. Cabral1, Daniel Eberli3,  
Cláudia L. da Silva1 & Pedro M. Baptista2,6,7
Patients with stress urinary incontinence mainly suffer from malfunction of the urethra closure 
mechanism. We established the decellularization of porcine urethras to produce acellular urethra 
bioscaffolds for future tissue engineering applications, using bioscaffolds or bioscaffold-derived 
soluble products. Cellular removal was evaluated by H&E, DAPI and DNA quantification. The presence 
of specific ECM proteins was assessed through immunofluorescence staining and colorimetric 
assay kits. Human skeletal muscle myoblasts, muscle progenitor cells and adipose-derived stromal 
vascular fractions were used to evaluate the recellularization of the acellular urethra bioscaffolds. The 
mechanochemical decellularization system removed ~93% of tissue’s DNA, generally preserving ECM’s 
components and microarchitecture. Recellularization was achieved, though methodological advances 
are required regarding cell seeding strategies and functional assessment. Through microdissection and 
partial digestion, different urethra ECM-derived coating substrates were formulated (i.e. containing 
smooth or skeletal muscle ECM) and used to culture MPCs in vitro. The skeletal muscle ECM substrates 
enhanced fiber formation leading to the expression of the main skeletal muscle-related proteins and 
genes, as confirmed by immunofluorescence and RT-qPCR. The described methodology produced a 
urethra bioscaffold that retained vital ECM proteins and was liable to cell repopulation, a crucial first 
step towards the generation of urethra bioscaffold-based Tissue Engineering products.
Urinary incontinence (UI) affects over 200 million people worldwide and has become more frequent with the 
increasing age of the population. UI is especially prevalent in women relating to childbirth injuries to muscle, 
connective tissue and nerves, but also age and obesity, among others1. Stress urinary incontinence (SUI) is the 
most prevalent type (4–35% of women worldwide)2,3. Most SUI patients suffer from malfunction of the urethra 
closure mechanism, the so-called external urethral sphincter or rhabdosphincter (RBS)4,5. The RBS is populated 
with skeletal muscle myofibers and is located in humans at the mid-urethra (Figure S1a); distinctly, in female 
pigs, this layer is located at the distal third of the urethra, while in male pigs it is located between the prostatic 
urethra and the penile urethra2,4,5. The urethra internal mucosal layer and smooth muscle play additional roles on 
the normal function of the urethra closure mechanism (Figure S1b)2,4,5. Within the scope of this work, only the 
intrinsic muscle-related causes for SUI were considered relevant.
Current treatments include pharmacological therapies, physiotherapy and surgical techniques with limited 
efficacy and wide variations between patients while being potentially accompanied by significant side effects 
(e.g. chronic inflammation)6,7. Hence, alternative therapeutic approaches including tissue engineering using stem/
progenitor cells and/or their derived progeny to rescue tissue function are urgently needed. The complexity of 
urethral functioning and more specifically the skeletal muscle in vivo environment8 implies therapies that explore 
the importance of cell-extracellular matrix (ECM) interactions, which are essential for skeletal muscle formation, 
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regeneration and proper function9. To do so, naturally-derived and tissue-specific ECM can serve as a basis to 
develop tissue engineering products for SUI therapies. In 2009, Zhang and colleagues demonstrated the dramatic 
effect of tissue-specific ECM compounds on the enhancement of cell proliferation and differentiation from each 
specific tissue10. So, such matrices can provide pivotal information about tissue-specific niches and be used to 
develop a reliable in vitro human model of SUI to test new therapies and drugs, since most work has been per-
formed in vivo, using animal models11. Furthermore, these matrices can serve as a starting material for the devel-
opment of tissue engineering products.
Naturally derived matrices can be obtained through organ/tissue decellularization to produce bioscaffolds 
that retain a similar composition, microstructure and biomechanical properties as the native tissue/organ while 
preserving most of the signaling cues required for organ development, repair and physiological regeneration12. 
These bioscaffolds can be later repopulated with other cell types to generate a ‘neo’ organ12. Multiple decellular-
ization techniques have been developed for distinct tissues and organs to find a balance between cell removal 
and ECM maintenance13, because insufficient decellularization holds cellular debris that elicit pro-inflammatory 
responses. However, on the other hand, aggressive and complete decellularization will bleach growth factors and 
denature proteins. Perfusion decellularization preserves both biochemical and architectural features of the natural 
tissue14–16. The safety and therapeutic relevance of decellularized bioscaffolds has been demonstrated with the 
implantation of decellularized bladder and small intestine submucosa ECM17,18.
Inability to efficiently decellularize urethral tissue19 has delayed the generation of an in vitro RBS. Hence, the 
use of acellular native urethra ECM (with preserved RBS) may be vital in the quest of bioengineering physio-
logically relevant urethral tissues. Ultimately, this will facilitate bioengineering the RBS in vitro, something that 
is rather difficult to accomplish with other synthetic or naturally-derived scaffolds that do not present the same 
microarchitecture.
Targeting more direct routes into clinical applications, these acellular ECM bioscaffolds have been solubilized 
to produce muscle specific ECM-derived protein mixtures20,21. These rich protein mixtures enclose tissue-specific 
biochemical cues and can be used for clinical product formulation.
Seeded and non-seeded biomaterials have already been used to regenerate urethral tissue while promoting 
neo-vascularization and stratification of the ingrowing tissue19,22. In 1998, Kropp and co-workers reported the 
successful use of small intestine submucosa (SIS) to evoke urethra regeneration in rabbits, focusing on urethral 
columnar epithelium and smooth muscle bundles22. More recently, in 2015, De Filippo and colleagues used acel-
lular collagen matrices derived from decellularized porcine bladders to create seeded tubularized grafts for ure-
thra repair23. These structures were seeded with autologous smooth muscle cells and then transplanted into 3 cm 
urethral defects in rabbits. Although the accomplished results were promising, reporting the formation of new 
tissue, which is histologically and functionally similar to the native urethra, the study did not focus on the RBS 
section of the urethra. In fact, regardless the matrix that was used, most reports are mainly focused on smooth 
muscle and urothelium layers, which are not the key players in the proper functioning of the urethral closure 
mechanism. To address SUI and take therapies to the next level, it will be crucial to explore the use of skeletal 
muscle cells (i.e. main contributors for sphincter functioning).
To the best of our knowledge, this is the first report of whole urethra decellularization, including the skeletal 
muscle layer. Inspired by previous work on whole-organ decellularization14,15,24, the main goal of this work was 
to establish an efficient decellularization method to generate acellular urethra bioscaffolds derived from porcine 
urethras. In this pilot study, we firstly developed a simple perfusion decellularization method to create urethra 
bioscaffolds, and secondly assessed cell behavior on (i) the developed bioscaffolds and (ii) bioscaffold-derived 
soluble products. Thus, the novelty of this study resides on the development of a putative substitute for the use 
of those scaffolds that do not recapitulate the native tissue but rather use an acellular native-derived bioscaffold, 
which will virtually hold all the main urethral properties and characteristics. Results show that these bioscaffolds 
hold the main properties and characteristics of the in vivo urethra environment and may serve as a foundation for 
the development and enhancement of tissue engineering-based SUI therapies.
Methods
Study Design. Urethras (n = 17: female, n = 9 and male, n = 8) were obtained from cadaveric female 
Yorkshire piglets (Group 1: 8.2 ± 3.8 Kg, n = 11) and Duroc male and F1 Large White X Landrace pigs (Group 
2: 31 ± 3.9 Kg, n = 6). Cadaveric animals were provided from experimental studies approved by the Animal 
Care and Use Committee (ACUC) of Wake Forest University Health Sciences in USA and Direcção Geral de 
Alimentação e Veterinária (DGAV) in Portugal25. Animal handling and dissections were performed in accord-
ance with guidelines and regulations of ACUC and DGAV. Thirteen urethras were used for decellularization while 
four were left intact and used to characterize the native tissue. Porcine urethras were decellularized using a mech-
anochemical process and subsequently characterized to evaluate the decellularization extent and the composition 
of the obtained bioscaffold. Envisioning the future generation of urethra bioscaffold-based tissue engineering 
products, cell behaviour was assessed in two culture platforms: (1) urethra rhabdosphincter bioscaffold sections 
and (2) urethra rhabdosphincter ECM-derived coatings (i.e. to explore the potential of solubilized ECM for future 
therapeutic product formulation). The impact of different urethra muscle ECMs (smooth and skeletal) on skeletal 
muscle fiber formation was further assessed on the ECM-derived coatings experiments to unravel the need of 
tissue-specific urethra muscle ECMs in further clinical product formulation for RBS-related SUI therapies.
Decellularization of porcine urethras. A step-wise representation of the decellularization protocol is 
showed in Table 1. Whole lower urinary tract (LUT) was dissected and prepared for the decellularization appa-
ratus (Supplementary Figure S2): the urethra was cannulated with a 14-gauge (14 G) cannula (Jelco® ) at its most 
distal region while a small incision was made at the top of the bladder.
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The decellularization apparatus (Figure S2) consisted of a peristaltic pump (Masterflex L/S peristaltic pump 
with Masterflex L/S easy load pump head and L/S 14 tubing), a magnetic stirrer plate (Fisher-ScientificTM,) and 
a 2 L glass beaker. The system was based on perfusion (40 ml/min) on the inside surface of the tissue and agita-
tion (60 rpm) on the outer surface of the tissue (Supplementary Figure S2). Parameters were set based on previ-
ous literature data and preliminary experiments. The LUT was immersed and perfused with distilled water for 
approximately 30 min. Subsequently, each decellularization solution was tested: 1% Triton X-100 (Sigma©) and 
0.1% Ammonium Hydroxide (NH4OH, Fischer-ScientificTM) (n = 2), 5% Triton X-100 and 0.5% NH4OH (n = 2), 
0.1% Sodium Dodecyl Sulfate (SDS, Sigma® ) (n = 2), 0.5% SDS (n = 5) and 1% SDS (n = 2). For 5 days, the organ 
was perfused with an accumulated volume of 288 L of the tested decellularization solutions that were renewed 
every 24 h. After the first 48 h, the direction of the perfusion was reversed (Supplementary Figure S2, grey arrows) 
- cannula moved from the urethra to the incision in the bladder to enhance the decellularization efficiency and 
homogeneity. The estimated pressure of the perfusate in the urethra was 110.1 N/m2, 117.8 N/m2 and 113.4 N/m2 
using distilled water, Triton X-100 and SDS solutions, respectively. The pressure (P) was calculated based on the 
data shown in Supplementary Table S1. The calculations were made using Equation (1) where F is force (N), Q 
is flow rate (m3/s), V is velocity (m/s) and ρ is the density (Kg/m3) of the solution. Distilled water was perfused 
through the tissue for at least 12 h to wash all the detergent remnants.
ρ=F Q x V x (1)
Urethra Rhabdosphincter Bioscaffold Characterization. Samples of native (n = 4) and decellularized 
(n = 5, 0.5% SDS and n = 2, 1% SDS) urethra were lyophilized (Labconco® ) and weighed. DNA was extracted 
with DNeasy Blood and Tissue Kit (Qiagen Inc.), according to manufacturer’s instructions. DNA concentration 
was determined using NanoDrop (Thermo ScientificTM).
The structure of decellularized bioscaffolds and native urethras was evaluated through scanning electron 
microscopy (SEM). Briefly, native tissue (n = 2) and decellularized bioscaffold sections (n = 3) were fixed with 
4% (v/v) formaldehyde (ThermoFisher©) in phosphate buffered saline (PBS, Gibco® ) (pH 7.2). Sections were 
then flash frozen in liquid nitrogen, lyophilized, and observed via SEM (Environmental Scanning Electron 
Microscope: SEM-Quanta FEG-250, ESEM).
Native (n = 4) and decellularized (n = 5, 0.5% SDS and n = 2, 1% SDS) urethras were fixed with 10% buffered 
formalin (NBF, Sigma©) and processed for paraffin embedding. Sections (5 μ m thick) were stained with hematox-
ylin and eosin (H&E, Dako®). ECM components were identified through immunofluorescence. Sections of native 
(n = 4) and decellularized (n = 5) urethras were processed for immunofluorescence staining. The antibodies were 
anti-collagen I-IV (1:50, Southern Biotech), fibronectin (1:200, Santa Cruz Biotech.), elastin (1:50, Santa Cruz 
Biotech.) and laminin (1:200, Sigma® ) and secondary Alexa 594-conjugated goat anti-rabbit and donkey anti-goat 
(1:200, InvitrogenTM). Slides were mounted with ProLong® Gold Antifade reagent with DAPI (InvitrogenTM). All 
images were captured on a Leica Microsystems DM4000B upright microscope (Leica Microsystems Inc.) and 
Image-Pro® Express software (Media Cybernetics Inc.).
Collagen, sulfated glycosaminoglycans (sGAGs) and elastin levels in native (n = 3) and decellularized (n = 3, 
0.5% SDS) were quantified using the Sircol Soluble Collagen, the Blyscan sGAG and the Fastin Elastin Assay 
Kits (Biocolor Ltd), respectively, according to the manufacturer’s instructions. Quantification was determined 
based on the absorbance at 555 nm, 656 nm and 513 nm, respectively, using a microplate reader SpectraMax M5 
Multi-Mode Microplate Reader (Molecular Devices Inc.).
Recellularization of Urethra Rhabdosphincter Bioscaffolds. Three hundred μ m thick cross-sectional 
acellular urethra bioscaffold sections (n = 25, from 2 urethra RBS bioscaffolds) were produced using a cry-
ostat (C3050S, Leica Microsystems Inc.). Sections had roughly 1 cm2 of surface area and were cut from the 
RBS-containing section of the urethra bioscaffold (i.e. containing mucosa and smooth and skeletal muscle ECM). 
Step Time (h) Conditions Aim
Urethra dissection 0.5 N/A Remove adipose tissue
Urethra cannulation 0.2 14 G cannula and surgical suture Fix the cannula to one extremity of the urethra
Mount decellularization apparatus 0.2 Supplementary Figure S2 Attach the cannula to the perfusion tubing system
Wash urethra 0.5 Distilled water: 40 ml/min + 60 rpm Wash out blood and debris
Add detergent solution 0.1 Detergent solution (details in Methods) Replace distilled water by detergent solution
Start decellularization process 48 40 ml/min + 60 rpm Remove cellular components of the tissue and preserve the ECM
Change perfusion direction 0.2 Change the cannula from one extremity of the urethra to the other
Allow both extremities to be equally exposed to 
the perfusion forces
Continue decellularization process 72 40 ml/min + 60 rpm Remove cellular components of the tissue and preserve the ECM
Wash bioscaffold ≥ 12 Distilled water: 40 ml/min + 60 rpm Remove detergent remnants
Total ≥ 133.7
Table 1.  Step-wise representation of the established protocol for the decellularization of porcine urethras. 
N/A: not applicable.
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Sections were directly collected into ultra-low attachment Costar® tissue culture plates (Sigma©), washed and 
sterilized with antibiotics and antimycotics in PBS (1:100, Gibco® ) and stored at 4 °C in PBS (Gibco® ). Prior 
to cell seeding, sections were emulsified in culture medium for at least 30 min at 37 °C. Different types of cells 
(details in Supplementary Materials and Methods) were individually seeded on the bioscaffolds by deposition 
with a micropipette. Briefly, sections were first semi-dried to adhere to the tissue culture plate surface. Then. 
droplets of highly concentrated cell suspensions (around 10 μ l each droplet, ~100 μ l total with approximately 
2 × 106 cells) were deposited on top of each section. The seeded-sections were kept at 37 °C for 30–40 min and 
then culture medium was carefully added to each tissue culture plate.
Sections were seeded with (2 × 106 cells) human muscle progenitor cells (MPCs, n = 9, from (Zenbio® ) or 
freshly isolated from muscle tissue of healthy donors at the University Hospital Zurich (USZ) in Switzerland26 
(Supplementary Methods) in growth medium. After 2 days, myoblast fusion was promoted using Dulbecco’s 
modified Eagle’s medium (DMEM) /F12 (Gibco® ) supplemented with 10% Fetal Bovine Serum (FBS, Gibco® ). 
MPCs proliferation was determined using 1:10 WST-1 (Roche©) in growth medium for 4 h at 37 °C (days 3, 5, 7, 
9, 11 and 14). Absorbance was measured at 450 nm in a Cytation 3 microplate reader (BioTek® ). As assay control, 
an unseeded bioscaffold section was used.
Human bone marrow mesenchymal stem/stromal cells (BM MSC, n = 2, Supplementary Methods27) and L929 
fibroblasts (n = 2, Leibniz-Institute DSMZ) (cell types similar to the stromal cell populations present in native 
rhabdosphincter) were seeded separately onto the sections (2 × 106 cells) using DMEM + 10% FBS. Cell prolifer-
ation was assessed with anti- Ki-67 FITC (1:200, BD Biosciences).
Stromal vascular fractions (SVF, Supplementary Methods28) were cultured (2 × 106 cells) on the sections in 
the presence of DMEM + 10% FBS (n = 6) or Skeletal Muscle Cell Growth Medium (SkMGM, ZenBio® , n = 2) or 
DMEM + 2% Horse Serum (HS, Gibco® , n = 4). All cultures were maintained at 37 °C and 5% CO2 with medium 
changes every 3 days.
Cell Culture on Urethra Rhabdosphincter Bioscaffold-Derived ECM Coatings. Skeletal and 
smooth muscle ECM environments (skECM and smECM, respectively) were isolated through microdissection 
(Supplementary Methods and Supplementary Figure S3). Prior to processing, smECM (n = 4) and skECM (n = 4) 
were washed overnight with isopropyl alcohol (IPA, Sigma©) followed by distilled water washing. The samples 
were milled in liquid nitrogen and the ECM was solubilized (10:1) using 4 mg/ml pepsin solution (Sigma©) 
dissolved in 0.01 M hydrochloric acid (HCl, Sigma©) under constant stirring. After 48 h, pepsin was inacti-
vated by bringing the pH to 8.5–9.0 using sterile-filtered sodium hydroxide (NaOH, Sigma©). The solution was 
brought to physiological pH by adding sterile filtered hydrochloric acid (HCl, Sigma©) and 10X PBS (Gibco® ) at 
4 °C. smECM and skECM solutions (140 and 180 μ g/ml, respectively) were used as coating substrates for MPCs 
culture. Cells were seeded at 5000 cells/cm2 and maintained in growth medium for 48 h. Fiber formation was 
induced using DMEM/F12 + 10% FBS for 14 days at 37 °C and 5% CO2 with medium changes every third day. As 
controls, MPCs were cultured on culture-grade polystyrene (no coating) or polystyrene surfaces coated with FBS. 
Cell proliferation was determined using WST-1 (Roche©), as mentioned previously. As assay control, a mixture 
of growth medium and WST-1 without cells was used.
Cell length and circularity were measured using ImageJ 1.49 software from the National Institutes of Health, 
USA. Measurements were determined based on 6 cells in at least 8 pictures (at least n = 48) per condition. Cell 
circularity was determined according to Equation (2), where Pr is the perimeter and Ar is the area of the cell.
Π
=Cell circularity x x Ar
Pr
4
(2)2
Immunohistochemistry Staining. Anti-desmin (1:200, Santa Cruz Biotech.), anti-MyoD (1:100, BD 
Biosciences), anti-Pax3 (1:100, Santa Cruz Biotech.), anti-Myosin Heavy Chain (anti-MHC, 1:200, Biolegend® ), 
CD31 (1:30, Dako® ), anti-Calponin (1:100, Abcam® ), anti-Vimentin (1:100, Dako® ) and anti-α -actin (1:180, BD 
Biosciences) antibodies were used. Novolink Polymer Detection System (Leica Microsystems Inc.) and Vectastain 
Elite ABC Kit (Vectorlabs® ) were used for labeling mouse/rabbit and goat antibodies, respectively. Nuclei were 
counterstained with Mayers’s hematoxylin (Sigma® ) and images were captured on an Olympus BX51 microscope 
and a DP21 Digital Camera (Olympus).
Immunofluorescence Staining. Cultures were fixed in 4% paraformaldehyde (PFA, Gibco® ) and per-
meabilized in 0.5% Triton X-100 in PBS. Protein blocking was completed using 5% bovine serum albumin 
(BSA, Sigma©) in 0.1% Triton X-100. Primary antibodies anti-desmin (1:50, Sigma©), anti-MyoD (1:100, BD 
Biosciences), anti-α -actinin (1:500, Sigma©) and anti-MyHC (1:1, DSHB) were incubated overnight at 4 °C. 
Secondary antibody Cy3-conjugated sheep anti-mouse (1:1000, Sigma©) was incubated for 1 h at room tempera-
ture in the dark. Cell nuclei were stained with DAPI (1:100, Sigma©). Images were acquired with Leica DM6000 
B microscope and LAS AF software both from Leica Microsystems Inc.
Fiber Formation Assay. Fiber formation (Supplementary Methods) was assessed through Giemsa staining 
(J.T. Baker® ). Cultures were fixed in ice cold methanol for 7 min. A 1:20 Giemsa solution was incubated at room 
temperature for 40–50 min. Images were acquired with Zeiss Axiovert 40 CFL and AxioVision SE64 Rel. 4.9 soft-
ware. A total of 10 high power fields (HPF) from each condition were analyzed. Results were expressed as fusion 
rate (%), calculated using Equation (3).
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=Fusion Rate Number of nuclei in fiber per HPF
Total number of nuclei per HPF
(%)
(3)
Statistics. All data was expressed as mean ± standard error of the mean (SEM). One-way ANOVA was used 
for statistical analysis. Statistical differences between groups from the same experimental set were determined 
using Turkey post-hoc test. Alternatively, when appropriate, independent t-test or Mann-Whitney U test were 
used when the samples did not show equal variance in the Levene Test. Statistical analyses were performed using 
SPSS Statistics software (IBM Corp, Armonk, NY, USA). A p-value < 0.05 was considered significant.
Results
Harvested urethras had around 5.1 ± 1.1 cm of length in group 1 and 7.1 ± 1.4 cm in group 2. Female urethras 
had an average length of 4.7 ± 1.6 cm, while male urethras had 6.6 ± 1.8 cm. In this work both female and male 
porcine urethras were used to test the decellularization method and evaluate its feasibility (only the pelvic section 
of the male urethra was used – the anatomical localization of the male RBS).
Decellularization of Porcine Urethras. Decellularization efficacy was initially determined by macro-
scopic visualization – tissue became white or transparent due to progressive cell removal (Fig. 1a and b). Only 
0.5% and 1% SDS showed macroscopic evidence of decellularization (Supplementary Table S2). Triton X-100 
solutions led to a minor discoloration of the tissue and 0.1% SDS solution showed an overall discoloration of the 
tissue, however, approximately 30% of the organ was not completely white/transparent (data not shown). Tissue 
decellularization was further confirmed by H&E staining (Fig. 1c–e and Supplementary Figures S4). Tissues 
subjected to 0.5% and 1% SDS displayed no basophilic purple staining (Fig. 1d and e). Additionally, the absence 
of relevant DAPI staining (Supplementary Methods and Supplementary Figure S5) confirmed that most cellular 
nuclear material was removed after emulsification with the detergent. Urethras decellularized with other deter-
gent solutions presented cell remnants by the basophilic dark purple staining (Supplementary Figure S4).
Quantification of cell removal was determined based on DNA quantification in the conditions that showed no 
cell presence on H&E and DAPI stainings (i.e. 0.5% and 1% SDS, Fig. 1f). The 0.5% SDS removed 93 ± 2.6% of 
total DNA (i.e. 629 ± 46.6 ng/mg tissue versus 9470 ± 2436 ng/mg tissue in native urethra, p-value = 0.01), while 
1% SDS removed 96 ± 0.2% of total DNA (i.e. 383 ± 17.4 ng/mg tissue versus 9470 ± 2436 ng/mg tissue in native 
urethra, p-value = 0.02). Since 0.5% SDS has a lower detergent concentration (i.e. a presumed milder action over 
ECM proteins), further studies were pursued using this solution. Detailed evaluation of the decellularization 
extent in each urethra tissue layer revealed no positive nuclear staining in neither muscle layers (skeletal, Fig. 1g 
marked with * and smooth, Fig. 1h) nor the mucosa (Fig. 1i) when compared with the native urethra (Fig. 1j–1l). 
Regardless the group of animals from which the samples were harvested, there were no detectable differences 
in the decellularization outcome, demonstrating the feasibility of the process in either shorter or longer organs.
Figure 1. Urethra decellularization. Macroscopic appearance of the lower urinary tract (a) before and  
(b) after decellularization. Pictures are from a urethra exposed to 0.5% SDS solution. (c–e) H&E staining of 
(c) native and (d and e) decellularized bioscaffolds (d, 0.5% SDS and e, 1% SDS). Images are from 5 μ m thick 
sections (*skeletal muscle and ⦁ smooth muscle). Scale bar: 50 μ m. (f) Quantification of remaining DNA in 
bioscaffolds using 0.5% and 1% SDS solutions. Results as mean ± SEM, *p ≤ 0.05, **p ≤ 0.01, t-test. Percentage 
of DNA is referred to the native tissue (assumed as 100% DNA content). Close up of (g–l) H&E staining of  
(g–i) native and (j–l) decellularized bioscaffolds in the three layers of the urethra: (g and j, in j marked with*) 
skeletal muscle, (h and k) smooth muscle and (i and l) mucosa. Scale bar: 50 μ m. (m–p) SEM evaluation of 
(m and o) longitudinal and (n and p) transversal cuts of (o–p) native urethra and (m,n) 0.5% decellularized 
bioscaffold (*, skeletal muscle, ⦁ , smooth muscle and ♢, mucosa). Scale bar: 250 μ m.
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Structure and Biochemical Composition of the Urethra Bioscaffold. SEM analysis revealed 
a similar ECM microarchitecture between the urethra bioscaffold and the native tissue (Fig. 1m–p and 
Supplementary Figure S6). Collagen was observed in all areas of the tissue, but mainly in the muscle layers. 
Collagens I and IV revealed higher abundance in the ECM when compared to the other two collagens that were 
tested (Fig. 2a,b and g,h versus Fig. 2c,d and 2e,f). Elastin and fibronectin showed a lower presence when com-
pared with all the other ECM proteins that were tested (Fig. 2i,j and 2k,l). Laminin distribution was particu-
larly intense in vessels, as well as in both muscle layers (Fig. 2m,n). Overall, there were no major changes when 
comparing ECM distribution in native urethra and acellular urethra bioscaffolds (Fig. 2 right panel versus left 
panel). Nevertheless, elastin showed an apparent decrease in the bioscaffold (Fig. 2i and j). ECM protein quan-
tification (Table 2) indicated that 20.8 ± 2.45% of the dry weight of the urethra bioscaffold was collagen, which 
was significantly higher (p-value = 0.01) than the quantity found in native tissue (5.0 ± 0.65%). The apparent 
increase is explained by the efficient removal of cellular material in the decellularization process, changing the 
final ratio of ECM/cellular proteins. Similarly, GAGs composed 5.4 ± 0.35% of the urethra bioscaffold while only 
2.8 ± 1.22% (p-value = 0.03) were detected in the native urethra. Finally, elastin quantification confirmed a sig-
nificant decrease (p-value = 0.01) of this protein in the bioscaffold treated with 0.5% SDS (18.3 ± 1.63%) when 
compared to the native tissue (37.7 ± 5.15%).
Recellularization of the Urethra RBS Bioscaffolds. Regardless the final application, bioscaffold recel-
lularization is unequivocally required. In this pilot study, recellularization was mainly evaluated through cell 
adhesion and behavior of MPCs, BM MSC and L929 cells on the urethra bioscaffolds sections. The initial cell 
seeding density in the bioscaffolds was determined based on previous knowledge and other work reported in the 
literature29–31. Fiber fusion potential of MPCs used to repopulate the bioscaffolds was previously tested in in vitro 
standard culture conditions (methods described in Supplementary Methods). In standard culture conditions, 
MPCs fused and formed multinucleated fibers that expressed the main skeletal muscle markers (Supplementary 
Figures S7 and S8) and spontaneously contracted after 14 days of myogenic induction (Supplementary Video S1).
MPCs were able to repopulate the bioscaffold sections and differentiate into multinucleated fibers (Fig. 3a, 
black arrows), especially in the peripheral/external surface of the bioscaffolds, where the RBS is located. BM MSC 
and L929 cells showed a more homogenous pattern throughout the bioscaffold (Fig. 3b and c). Cells did not only 
repopulate the surface area of the bioscaffold but also penetrated the 3D structure as confirmed by the H&E stain-
ing of sequential recellularized bioscaffold sections (data not shown). Cellular expansion in the bioscaffold was 
determined via immunofluorescence staining for the proliferation marker Ki-67 (Fig. 3d–f). This showed L929 
cells proliferating in the scaffold (Fig. 3f), even after 2 weeks in culture. The seeded MPCs and BM MSC showed 
no positive staining for Ki-67 after 2 weeks in culture (Fig. 3d and e). For MPCs, the lack of cellular proliferation 
at day 14 is in accordance with the observed cellular differentiation/myofiber formation (Fig. 3a).
Cell proliferation in the bioscaffolds was assessed using MPCs (Fig. 3g). Maximum cell proliferation (around 
the values attained in standard culture conditions) was reached after 5 days (Fig. 3g), while after this point, cell 
proliferation significantly decrease around 50% (p-value = 0.001). This may be related to bioscaffold contraction 
and “collapse” due to initial cell proliferation. At day 3 (Fig. 3i) the bioscaffold already showed contraction and 
decreased surface area when compared to day 1 (Fig. 3h). Bioscaffold contraction and “collapse” was even more 
evident after day 7 (Fig. 3j and k). Nevertheless, since the 3D cultures were performed under static conditions, 
diffusional limitations might have occurred turning nutrient/oxygen supply to cells and metabolic waste removal 
inefficient.
Myoblasts that repopulated the bioscaffold fused to form multinucleated fibers, expressing the main skeletal 
muscle markers after 2 weeks of myogenic induction (Fig. 4). Fusion rate was 19 ± 3% in the bioscaffolds, showing 
6.8 ± 0.8 fibers/HPF and 3.6 ± 0.1 nuclei/fiber. These values were not significantly different from the ones attained 
in standard culture conditions (p-value > 0.05, 34 ± 3% fiber fusion, 3.9 ± 0.5 fibers/HPF and 7.8 ± 1.2 nuclei/
fiber).
The behavior of heterogeneous cell populations in the bioscaffolds was assessed with adipose-derived SVF 
populations (Supplementary Figure S9). In the presence of standard culture medium (DMEM + 10% FBS), these 
cells gave rise to structures that were positive for the presence of actin, calponin, MyoD, MyHC (although the 
staining is weak) and vimentin (Supplementary Figure S9a–S9d and S9f). Importantly, SVF populations gave 
rise to CD31 + structures, which are crucial for tissue formation and regeneration. After myogenic induction 
(DMEM + 2% HS), SVF-derived cells gave rise to structures positive for both muscle (actin, calponin, MyoD and 
MyHC) and stromal (vimentin) markers (Supplementary Figure S9g–S9k).
In Vitro Culture using Urethra ECM-based Coatings. To explore further urethra bioscaffold applica-
tions, we used protein extracts from both urethra skeletal (skECM) and smooth (smECM) muscle ECM as coat-
ing substrates for in vitro culture. By separating the two tissue-specific urethra muscle ECMs, we assessed the 
impact of each biochemical environment on skeletal muscle fiber formation and protein expression.
MPCs remained viable in all ECM substrates (Supplementary Methods and Supplementary Figure S10), 
showing no significant differences in cell proliferation (p-value > 0.05, Supplementary Figure S10). Microscopic 
visualization indicated apparent cell morphology differences upon initial cell seeding on the different substrates 
(Supplementary Figure S10). MPCs showed a significant longer morphology on skECM coatings (109 ± 4.9 μ m) 
when compared to all other coatings (50 ± 3.1 μ m, p-value = 0.0001 and 80 ± 4.3 μ m, p-value = 0.003 for FBS 
and smECM, respectively, Fig. 5a), while showing no significant differences in cell circularity (Fig. 5b). Still, 
MPCs on smECM coatings were significantly more circular when compared to all other coatings (0.53 ± 0.03, 
p-value = 0.001, Fig. 5b).
The highest fiber fusion rates were obtained in skECM (20 ± 1.4%) and FBS (21 ± 2.4%) substrates (Fig. 5c). 
The fusion rate on skECM coatings was not significantly different from the control conditions (p-value = 0.074). 
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Figure 2. Urethra decellularization. Immunofluorescence staining of (a,c,e,g,I,k and m) native urethra and 
(b,d,f,h,j,l and n) bioscaffolds generated using a 0.5% SDS solution (*skeletal and ⦁ smooth muscle layers): 
collagens I to IV (a–h), elastin (i–j), fibronectin (k–l) and laminin (m,n) were tested. Images are from 5 μ m 
thick sections. Scale bar: 100 μ m.
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Still, the fusion rate acquired using skECM was significantly higher than the one achieved using smECM sub-
strates (p-value = 0.035, Fig. 5c). Additionally, the number of fibers present in skECM coatings was significantly 
higher than in smECM (6.5 ± 0.52 versus 2.9 ± 0.31, p-value = 0.0001, Fig. 5d) and non-coated polystyrene 
(4.1 ± 0.34, p-value = 0.008, Fig. 5d). There were no differences in the number of nuclei per fiber (p-value = 0.059, 
Fig. 5e). All calculations were based on image analysis of Giemsa stainings (Fig. 5f–i).
The expression of skeletal muscle-related proteins and genes was evaluated in all substrates (Fig. 6 and 
Supplementary Figure S11, Supplementary Methods for RT-qPCR). While at the gene level no major differences 
were observed (Supplementary Figure S10), the immunofluorescence staining revealed differences according to 
the type of substrate (Fig. 6). The presence of desmin, MyHC and actinin was confirmed in all cultures. Still, in all 
conditions MyHC showed an apparent lower expression when compared to desmin and actinin (Fig. 6e–h versus 
all others). The stainings revealed an apparent higher expression of all proteins in MPCs cultured in urethra ECM 
(either skECM or smECM) when compared to the control conditions (Fig. 6). This was particularly evident for 
MyHC (Fig. 6g–h versus Fig. 6e–f). All together, these preliminary data indicates that urethra-specific ECM has 
an impact on cell behavior in culture, in a way that MPCs show better performance in ECM environments derived 
from actual skeletal muscle ECM.
Discussion
The biochemical, architectural and physiological complexity of the urethra environment, in which normal func-
tioning is highly dependent on cell-ECM interactions32–34, requires tissue engineering strategies that mimic, as 
much as possible, the native environment of the organ.
In recent years, tissue engineering has successfully progressed into the use of decellularized matrices12,13,35,36. 
Such matrices retain chemical and biological cues, while showing similar composition and microstructure as the 
native tissue13,37. These properties are crucial for tissue engineering approaches, making the decellularized matri-
ces a more physiological environment for the target cells13. The decellularization protocol and detergent are not 
universal and have to be optimized for each organ/tissue and individual applications/goals due to intrinsic factors 
such as cellular density, specific density, lipid content and thickness38.
To the best of our knowledge, this is the first report of whole urethra decellularization, including the RBS 
layer. Several groups have performed skeletal muscle decellularization of tissue fragments21,39,40. We used porcine 
urethras that are an excellent animal model to study and evaluate treatments for sphincter deficiencies due to its 
functional similarities with the human urethra4,5. We present a dynamic decellularization scheme for porcine 
urethras based on agitation and perfusion (of the external and internal surfaces of the organ, respectively). Our 
system combines perfusion forces and chemical emulsification in order to promote a more efficient and homoge-
neous cellular removal from the thick urethra fiber mesh13,38. Previous work on vascular tissue has demonstrated 
that the decellularization of thick and dense tissues, based exclusively on agitation is very limited and ineffective 
on generating a completely acellular bioscaffold41. This is because thicker tissues tend to decellularize well at the 
surface, while the cells at the inner core are preserved (the decellularized matrix at the surface forms a resistant 
layer preventing efficient access to the deeper tissue parenchyma). Additionally, many describe that perfusion 
forces contribute to a higher penetration of the chemical agent into the parenchyma increasing cell removal19,38,41. 
As Consolo and co-workers reported, mechanochemical decellularization processes are more effective on remov-
ing cellular material and maintaining the main tissue characteristics and properties than chemical approaches 
alone42. The male spongy urethra has been previously decellularized by Feng and colleagues using a 1% Triton 
X-100 solution (with no report on cell removal efficiency)43, still there are no reports on the decellularization 
of the urinary sphincter. In fact, most of the reports on skeletal muscle decellularization are not focused on 
urethra-derived skeletal muscle, but rather on abdominal and leg muscles39,44.
Based on the work of several groups on the decellularization of other organs/tissues14,24,45 and with the aim of 
keeping the decellularization process as simple as possible, we used two detergents: Triton X-100 and SDS. Triton 
X-100 disrupts lipid-lipid and lipid-protein bonds, having a milder action over the bonds between ECM proteins 
while SDS acts over protein-protein bonds, and so has a harsher effect on the ECM13,38. In this work, Triton X-100 
was not effective on generating acellular bioscaffolds. Consequently, the lower concentration of SDS that actu-
ally removed most of the cellular material from the tissue (i.e. 0.5% SDS) became the solution of choice. The use 
of this detergent in combination with two mechanical forces resulted in the removal of more than 90% of total 
DNA, generating acellular urethra bioscaffolds with no visible cellular content on H&E and DAPI stainings. These 
results are similar to others reported in the literature concerning liver, heart and lungs decellularization14,24,45. 
Recently, it was proposed the three-part criteria for tissue decellularization: (1) no visible nuclei in H&E and 
DAPI staining, (2) no more than 50 ng DNA/mg dry weight and (3) the remaining DNA should not exceed 
200 base pair in length38. Though, these criteria are still debatable and not followed by all groups and published 
reports46. Considering further clinical applications and according to the future criteria that will be set for decellu-
larized tissues, the protocol developed here will need to be further explored and optimized. Microstructure anal-
ysis showed that the decellularization method yielded an apparently intact and unaltered ECM microarchitecture 
Native Urethra Urethra Bioscaffold
Collagen (%) 5.0 ± 0.85 20.8 ± 2.45**
GAGs (%) 2.8 ± 1.22 5.4 ± 0.35*
Elastin (%) 37.7 ± 5.15 18.3 ± 1.63**
Table 2.  Quantification of ECM proteins through colorimetric assays in native urethra (n = 3) and urethra 
bioscaffolds (n = 3). Results as mean % in total dry mass ± SEM, *p ≤ 0.05, **p ≤ 0.01, Mann-Whitney U test.
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in the bioscaffold when compared to the native urethral tissue. Immunofluorescence confirmed no major qualita-
tive loss of ECM components, although elastin showed ~50% significant loss in the bioscaffold. Elastin is respon-
sible for mechanical strength and elasticity, essential properties for the normal contractile function of the urethra 
closure mechanism47 so it can be anticipated that this loss may have an impact on the mechanical properties of 
the bioscaffold (not assessed). Nevertheless, as this is majorly a structural protein, presumably it may not com-
promise recellularization. Furthermore, seeded cells will have the ability to remodel the bioscaffold by secreting 
matrix metalloproteinases (MMPs) and de novo ECM molecules, potentially restoring the native composition 
of urethra RBS bioscaffold29. Still, elastin expression is reduced with urogenital tissue aging48, so the chances of 
elastin restoration by the patient’s autologous cells in vitro is currently unknown. Collagens I and IV have been 
described as the most abundant components in urethra’s ECM as these provide structure and support to cells20. 
In this particular study, there was no evident loss of collagens. Fibronectin encodes cell adhesion peptide motifs 
(e.g. RGD motifs that bind to integrins)13,49 and it is especially important not only for cell adhesion, but also for 
cell growth, migration and differentiation. This protein is insoluble in most decellularization solutions and it is 
preserved in most decellularized organ scaffolds49, as it seems to be the case in the decellularized urethra RBS 
bioscaffolds described here. Finally, laminin is also vital for cell adhesion due to YIGSR and IKVAV polypeptide 
sequences that are similarly involved in cell adhesion13. Thus, the maintenance of these proteins is thought to be 
crucial to facilitate recellularization, by inducing cell adhesion, proliferation and migration13. Here, we only tested 
a strict group of ECM proteins, still it is important to address that there are virtually hundreds, if not thousands, 
of proteins in these naturally-derived ECM bioscaffolds50.
In this pilot study, SDS remnants were not quantified. Still, it has been shown by others that after prolonged 
washing the residual SDS content of a 1% SDS decellularized tissue is nearly negligible51. Additionally, the 
Figure 3. Recellularization of urethra bioscaffolds. (a–c) H&E staining and (d–f) Ki-67 (green) 
immunofluorescence staining of recellularized bioscaffolds using (a and d) MPCs, (b and e) BM MSCs and (c and 
f) L929 fibroblasts (14 days in culture, black arrows indicate multinucleated fibers). Scale bar: 100 μ m. Nuclei were 
stained with DAPI (in blue). (g) Ratio of total cells alive in relation to MPCs in standard culture conditions (WST-1 
assay, at 450 nm). Results as mean ± SEM (n = 3), ***p ≤ 0.001, ANOVA. (h–k) Morphological alterations of the 
bioscaffold due to contraction along time culture (h, day 1, i, day 3, j, day 7 and k, day 14). Scale bar: 1 cm.
Figure 4. Recellularization of urethra bioscaffold. Immunohistochemistry of bioscaffolds recellularized with 
MPCs after 14 days of myogenic induction. The presence of (a and b) Pax3, (c and d) α -actin, (e and f) MyoD, 
(g and h) MyHC and (i and j) desmin was evaluated at days 7 and 14. Scale bar: 100 μ m.
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presence of porcine viruses such as porcine endogenous retroviruses (PERV), hepatitis E and circoviruses was 
not assessed. Still, recent reports have shown that the decellularization of porcine livers using 0.1% SDS elimi-
nates swine leukocyte antigens as well as PERV DNA52. Furthermore, the required doses of gamma-irradiation 
(1.5–3.5 Mrad) enforced by most regulatory agencies (FDA and EMA) in the sterilization of naturally-derived 
matrices for human application are able to completely eliminate all the infectious agents from these products53,54. 
Ultimately, the decellularization protocol developed here can potentially be further adjusted and optimized for 
the decellularization of human urethras, yielding a xenogeneic-free product for clinical settings.
Figure 5. Evaluation of cell morphology and fiber formation on urethra ECM coatings. (a) Cell length  
(μ m) and (b) circularity were determined for a total of 60 cells per condition. (c) Fiber formation (n = 10 HPF) 
was evaluated through fusion rate (%), (d) number of fibers and (e) number of nuclei per fiber. Results as 
mean ± SEM, *p ≤ 0.05, **p ≤ 0.01, ****p ≤ 0.0001, all others are not significant, p > 0.05, ANOVA. (f–i) Giemsa 
stainings were used to quantify fiber formation. Scale bar: 50 μ m.
Figure 6. Expression of skeletal muscle-related markers in MPCs cultured on urethra ECM coatings.  
(a–d) Desmin, (e–h) MyHC and (i–l) α -actinin (red) was assessed through immunofluorescent staining on 
MPCs in differentiation for 14 days. Nuclei were stained with DAPI (blue). Scale bar: 50 μ m.
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Together, the decellularization data shows that the simple mechanochemical decellularization method pro-
posed here created acellular urethra bioscaffolds that in general retained the overall composition of the native 
tissue.
The recellularization potential of the urethra bioscaffolds and cell behavior upon culture were assessed. MPCs, 
BM MSCs, and SVF were seeded on the bioscaffolds due to their important role in muscle and sphincter forma-
tion as well as tissue regeneration55,56. These preliminary recellularization studies revealed that the bioscaffolds 
provided a suitable environment for cell adhesion, proliferation, and survival confirmed by the positive H&E 
and Ki-67 stainings and WST-1 assay. The presence and maintenance of these cells for up to 2 weeks in the bios-
caffolds demonstrated that the decellularization process potentially maintained the primary biochemical cues 
of the native tissue, allowing cells to repopulate the urethra ECM. It is noteworthy that the side-by-side use of 
immortalized cell lines (i.e. L929 fibroblasts) and primary cell cultures (i.e. all others) may introduce discrepan-
cies in the results, since immortalized cell lines display an abnormal behavior, representing only surrogate models 
for primary cells57. MPCs were able to proliferate and survive in the bioscaffold for up to 14 days, despite the 
notorious contraction and collapse of the 3D sections. This may be explained by cell contraction forces that were 
created after the formation of strong cell-cell and cell-ECM networks during proliferation58. Ultimately, the col-
lapse and the formation of an “ECM mass” may have led to inefficient nutrient supply and waste removal, which 
may explain the lower proliferation levels achieved after day 5. Nevertheless, the MPCs were able to fuse and form 
multinucleated structures expressing skeletal muscle markers, indicating that these cells were able to differentiate 
in the bioscaffold, showing lower proliferation rates (due to differentiation). When compared to standard culture 
conditions, fiber fusion in the bioscaffolds was lower (around 50% less). Still, the non-homogeneous distribution 
of cells and the existence of areas that are not conducive to the differentiation of skeletal muscle may explain the 
lower levels. Additionally, the 3D configuration of the bioscaffolds turns accurate quantification of fiber formation 
more difficult when compared to standard culture conditions where fibers are clearly seen and the nuclei inside 
each fiber can be easily identified.
Further seeding experiments using other cell types of interest (i.e. SVF) reassured the potential of the acel-
lular urethra bioscaffolds to support tissue formation. The rationale of using a heterogeneous cell population 
was not only due to its attractiveness for tissue engineering applications (i.e. rich content in stem and progenitor 
cells) but also to assess differential cell deposition in the bioscaffold. Through immunohistochemistry, it was 
confirmed that the SVF population gave rise to stromal, muscle and CD31-positive structures in the bioscaffold 
mesh. Noteworthy, the presence of endothelial-like structures was only detected in specific areas of the bioscaf-
fold, indicating that in fact cells may be more attracted to some areas of the ECM mesh than others.
Together, the recellularization data indicates that the decellularization process produced an ECM matrix that 
retained the complex biochemical and 3D architecture of the native urethra, providing a suitable environment for 
cell proliferation and differentiation. This matrix provided a microenvironmental blueprint for the seeded cells, 
shaping and influencing their behavior in the bioscaffold.
In the present study, the use of 3D bioscaffold sections was justified in order to simplify the studies of cell 
adhesion, proliferation and fiber formation. Nevertheless, the future goal would be the recellularization of whole 
urethra bioscaffolds using tailor designed bioreactors to create an in vitro urethra model.
The precise microdissection of the RBS from other urethra segments allowed the study of the importance 
of muscle tissue-specific urethra ECM on skeletal muscle cell behavior and differentiation. After solubilization, 
ECMs were used as coating substrates in standard culture conditions. MPCs showed no differences in cell prolif-
eration and viability when cultured in skECM or smECM (or even the control conditions). Importantly, upon cell 
seeding, cells showed different phenotypes according to the substrate in which they were cultured. Cells cultured 
on skECM were significantly longer than all others while the ones on smECM were more circular. The fiber for-
mation assay revealed a significant 8% higher fusion rate on skECM than on smECM as well as higher number 
of fibers that revealed positive staining for the main protein skeletal muscle markers (not so evident at the gene 
level), demonstrating that the skECM protein mixture provided a better support for cell spreading, alignment 
and fiber formation. Together, the preliminary data using smECM and skECM coatings demonstrates that, as 
reported in other tissues10, the use of tissue-specific ECM compounds is crucial to enhance the formation and 
regeneration of each specific tissue. Thus, if the target would be a RBS-related SUI therapy, the focus will need to 
be urethra skECM, besides whole urethra ECM, in order to potentiate the formation of a functional RBS.
Overall, despite the need for improved bioengineering strategies that potentiate myogenic induction 
(e.g. using adhesion proteins and/or specific signaling molecules to potentiate myogenesis), the results presented 
here are a first solid step in that direction. The acellular bioscaffold developed in this study serves as a starting 
platform for further studies on urethra/RBS bioengineering since it maintains the major characteristics of the 
native tissue. Ultimately, these bioscaffolds may be used for the development of RBS-ECM based products for 
tissue engineering strategies to treat SUI in order to potentiate skeletal muscle formation or to be directly used to 
develop urethra/RBS models in vitro.
Considering the importance of innervation in musculoskeletal regeneration and function59, it will be crucial 
to assess the behavior of nerve cells and neo-innervation in the urethra bioscaffolds developed here. To improve 
scaffold’s recellularization, surgical urethra dissection along with its vasculature will have to be explored as it has 
been with other organs/tissues5,14,38,60. The use of vasculature for recellularization would improve cell penetration 
into deeper regions of the urethra rhabdosphincter bioscaffold.
Conclusion
This pilot study provides a simple mechanochemical method to decellularize porcine urethras (containing the 
urethral rhabdosphincter - RBS), which yielded an acellular bioscaffold that retained the microstructure and 
overall biochemical composition of the native tissue. Despite the need for further improvements on recellulari-
zation, the produced bioscaffold was suitable for cell adhesion, proliferation and fiber formation yielding human 
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skeletal muscle-like structures expressing the typical myogenic markers. Cell culture on urethra smooth muscle 
and skeletal muscle derived substrates evidenced that tissue-specific ECM enhances cell behavior and ultimately 
cell function.
Finally, these bioscaffolds will serve as ideal platforms to extend the experience regarding cell seeding strate-
gies, ECM composition adjustment, function rescue and alternative cell-based therapies.
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